“No Patients – No Payment” risk-sharing program explained

Cromos Pharma launches video explaining its unique risk-sharing program, “No Patients – No Payment”, which aims to enhance the efficiency of clinical trial patient recruitment. The video explains how the US-based international CRO’s proprietary program benefits Sponsors and how they can take advantage of the offer.   Efficient patient recruitment for clinical trials  Patient recruitment is the largest challenge

Cromos named top Quality Assurance service provider by Pharma Tech Outlook

Cromos Pharma is proud to be recognized as one of Pharma Tech Outlook’s top Quality Assurance Service Providers. The latest edition which focuses on quality assurance features an interview with Cromos Pharma’s CEO Vlad Bogin.  “The pharmaceutical sector is challenged by a series of issues pertaining to clinical trials—patient recruitment, ensuring the safety of human subjects, maintaining consistency

Connect with Cromos Pharma at the 40th JP Morgan Healthcare Conference

The JP Morgan Healthcare Conference is recognized as one of the largest and most anticipated life science industry events. In this article Cromos Pharma’s CEO Vlad Bogin gives his take on the importance of participating in this week. You been attending for over 10 years – what has your experience been of the event thus far? I cannot think


TO FIND OUT MORE

INQUIRY@CROMOSPHARMA.COM